FindTrial
Sign In

AP214

DRUG3 trials

Sponsors

Action Pharma A/S

Conditions

Aortic AneurysmAortic Root or Ascending Aortic Aneurysm Repair SurgeryCardiac SurgeryCoronary Artery BypassCoronary Artery Bypass GraftingKidney DiseasesKidney InjuryValve Surgery

Phase 2

Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery
TerminatedNCT00628264
Action Pharma A/SCardiac Surgery, Coronary Artery Bypass Grafting, Kidney Injury +1
Start: 2008-03-31End: 2009-06-30Target: 75Updated: 2009-06-01
Pharmacokinetics of AP214 Acetate in Patients Undergoing Cardiac Surgery
CompletedNCT00903604
Action Pharma A/SAortic Root or Ascending Aortic Aneurysm Repair Surgery, Cardiac Surgery, Coronary Artery Bypass Grafting +1
Start: 2009-05-31End: 2010-06-30Updated: 2011-05-17
An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
CompletedNCT01256372
Action Pharma A/SAortic Aneurysm, Cardiac Surgery, Coronary Artery Bypass +2
Start: 2010-10-31End: 2011-08-31Updated: 2012-03-15

Related Papers

ABT‐719 for the Prevention of Acute Kidney Injury in Patients Undergoing High‐Risk Cardiac Surgery: A Randomized Phase 2b Clinical Trial
Journal of the American Heart Association2016-08-0840 citations